FDA approves AcuFocus' corneal implant

(Reuters) - The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. (http://1.usa.gov/1Hh1g7V) Presbyopia is a condition associated with aging in which the eye exhibits a diminished ability to focus on near objects. (Reporting by Rosmi Shaji in Bengaluru; Editing by Saumyadeb Chakrabarty)



via Health News Headlines - Yahoo News http://ift.tt/1GV1va2